                </a></li></ul></div><p><strong>Figure 8.  <span>Dose-response of EGFP mRNA levels to increasing amounts of nanoparticle DNA following subretinal injection.</span></strong></p><a id="article1.body1.sec3.fig8.caption1.p1" name="article1.body1.sec3.fig8.caption1.p1"></a><p>Multiple doses of the AC-GFP nanoparticles were diluted in saline and delivered via subretinal injection.</p>
<a id="article1.body1.sec3.fig8.caption1.p2" name="article1.body1.sec3.fig8.caption1.p2"></a><p>qRT-PCR was then performed to assess EGFP mRNA levels in relation to photoreceptor-specific genes.</p>
<a id="article1.body1.sec3.fig8.caption1.p3" name="article1.body1.sec3.fig8.caption1.p3"></a><p>An increasing trend of EGFP mRNA was detected in response to increasing levels of nanoparticle DNA delivered.</p>
<a id="article1.body1.sec3.fig8.caption1.p4" name="article1.body1.sec3.fig8.caption1.p4"></a><p>At the highest dose of 4 Âµg of DNA, the levels of EGFP were nearly 88% of rod opsin mRNA.</p>
<a id="article1.body1.sec3.fig8.caption1.p5" name="article1.body1.sec3.fig8.caption1.p5"></a><p>Lesser doses achieved expression levels near other photoreceptor-specific genes involved in blinding diseases.</p>
<a id="article1.body1.sec3.fig8.caption1.p6" name="article1.body1.sec3.fig8.caption1.p6"></a><p>Rho: Rhodopsin; Sag: S-Antigen (Arrestin); Gnat1: Guanine Nucleotide Binding Protein, Alpha Transducing 1; Rds: Retinal Degeneration Slow</p>
